Evolving AI Assistants Beyond Scribes

Unpacking How AI is Changing Healthcare

This Week in Health AI # 10 | Subscribe

Happy week before Christmas! We’ll be off for two weeks for the holidays (and doubting we’ll miss much as these are the slowest weeks of the year). A few interesting stories this week giving us an inkling on the future of AI scribes at the bedside.

Google Cloud Backed Suki Expands Product Offerings

 Suki, an AI healthcare assistant provider, has integrated Google Cloud's Vertex AI platform to introduce advanced patient summary and Q&A features. These upgrades aim to reduce administrative burdens for clinicians by offering quick patient insights and medical information retrieval starting in 2025​.

Key Takeaways

  • Strategic Partnership with Google Cloud: Suki integrates Vertex AI to power advanced Q&A and patient summary features, solidifying its position as an end-to-end clinical AI assistant.

  • Focus on Workflow Efficiency: The AI streamlines appointment prep and medical literature search, allowing clinicians to focus on patient care.

  • Expansion to General AI Assistant: New capabilities move Suki beyond transcription to clinical decision support, enhancing usability in diverse healthcare settings.

  • Broad Rollout in 2025: Features like drug interaction checks and patient summaries will be widely available without additional cost.

Why This Matters

We'll be seeing a big push over the next six months of scribe companies coming out with expanded service offerings to differentiate themselves in what's become a very crowded AI scribe market. Suki has gotten headlines for their partnership with Google Cloud (any of Google's efforts in health AI are worth keeping an eye on). The idea of a more comprehensive AI assistant for physicians and medical staff is deeply appealing, and we'll be interested to see if any of the scribe companies see broader adoption as they seek to expand their available tools. Full Article

New Jersey Health System Sees Mass Adoption of AI Agent Amongst Clinicians

 AtlantiCare, based in Atlantic City, N.J., has successfully implemented Oracle Health’s Clinical AI Agent(CAA), achieving an 80% adoption rate among its providers. The AI-powered tool focuses on ambient note generation and streamlining documentation to reduce administrative burdens.

Key Takeaways

  • Strong Early Adoption: AtlantiCare piloted the tool with 50 providers across multiple specialties, achieving an 80% adoption rate. Providers report growing satisfaction as the technology evolves.

  • Substantial Efficiency Gains: AtlantiCare is claiming the AI tool has led to a 42% reduction in documentation time across 6,000 visits, saving an average of 66 minutes per provider per day.

  • Collaborative Refinement: AtlantiCare’s partnership with Oracle includes direct feedback loops where providers actively influence enhancements, which has been key to the tool’s acceptance and ongoing improvement.

Why This Matters

This article touches on a key question that underlies the mass push in new AI tools into the healthcare market: are these technologies actually gaining traction? While I have some reservations about the robustness of the 80% adoption metric, it's encouraging to see some public pronouncements around the uptake in these technologies. Like the viability of the AI tools themselves, the adoption rate is only going to increase as the tools become more integrated, better designed, and increasingly powerful - but it's important to acknowledge that for many health systems, adoption of the existing tools is likely incredibly moderated. Full Article

Other Things Worth Checking Out

Here are some other developments that might be worth your time.

  • Google spinoff Verily plans major strategic shift in 2025, targeting healthcare AI and independence from Google while seeking new funding round. The company will aim to become a one-stop tech infrastructure provider for healthcare companies building AI models and apps.

  • GE HealthCare deepens AI investment with plans to triple FDA authorizations to 200+ by 2027. The company's "Health Companion" initiative explores multi-agent AI to replicate cancer care team expertise, while its AI platforms target radiologist workflow efficiency.

  • Business Insider provided a broad overview of the Healthcare AI startups ecosystem and some of the key players addressing the various opportunities in the sector. Abridge ($150M), Xaira ($1B), and Atropos ($33M) all secured significant funding as the industry shifts focus from hype to ROI and clinical validation.

  • Fierce Healthcare provided their own forward looking "outlook" on what to expect from AI scribes and virtual care in 2025. The AI scribe market is expected to consolidate from 60+ vendors to 6-7 major players. The article highlights how both providers and purchasers are demanding more proven ROI and specialty-specific solutions, while telehealth platforms are positioning themselves as the essential infrastructure layer for integrating these AI capabilities into healthcare delivery.

That’s it for now. We’ll catch up again after the new year week.

-Patrick

Enjoy this? Please take the time to forward to a friend or subscribe.